AlbionVC (Healthcare)

UK-based venture capital firm with dedicated healthcare and life sciences investment focus. Part of the broader Albion Capital Group, investing in innovative UK life sciences companies from early stage through growth.

Location
London, UK
Founded
2009
AUM
£500M+
Investment Range
£1M - £10M
Portfolio Companies
17
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Investment Thesis

AlbionVC Healthcare invests in UK-based life sciences and healthcare companies with differentiated technology platforms and strong intellectual property. They focus on companies that can achieve significant clinical and commercial milestones with their capital, supporting founders from seed through Series B and beyond.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Ed Sherwood - Partner, Healthcare
  • Christoph Sherwood - Investment Director

Other Key Team Members

  • Will Fraser-Allen - Managing Partner

Focus Areas

  • Therapeutics
  • Medical Devices
  • Diagnostics
  • Digital Health
  • Life Science Tools
  • UK Life Sciences

Notable Exits

  • Multiple UK life sciences exits and IPOs
  • Strong track record in UK healthcare technology

Sources

Portfolio Companies

NameLocationFoundedCategories
Apollo TherapeuticsCambridge, United Kingdom2016
biotechdrug-discovery+2
Arecor TherapeuticsCambridge, United Kingdom2007
biopharmadrug-formulation+3
Aridhia InformaticsEdinburgh, Scotland, United Kingdom2007
health-techdata-analytics+3
Axovia TherapeuticsCambridge, Massachusetts, USA2021
biotechgene-therapy+3
Bloomsbury Genetic Therapies (Bloomsbury GTX)London, United Kingdom2020
biotechgene-therapy+3
CISIVUnited States2020
clinical-trialsdecentralized-trials+2
CS GeneticsCambridge, UK2019
genomicssingle-cell+2
DexelaLondon, UK-
medical-imagingdiagnostics+2
DYSIS MedicalEdinburgh, UK2003
medical-devicesdiagnostics+3
Echopoint MedicalUK-
medical-devicescardiology+2
EpilepsyGTx--
gene-therapyepilepsy+3
Epilogen--
immuno-oncologyantibody-therapeutics+3
Evaro--
digital-healthpharmacy+2
Exco InTouchNottingham, UK2001
digital-healthclinical-research+2
Freeline TherapeuticsStevenage, United Kingdom2015
gene-therapybiotech+3
MeiraGTxNew York, New York, USA2015
gene-therapyophthalmology+3
Mirada MedicalOxford, United Kingdom2003
medical-imagingoncology+3